👁 Overview of TB Treatment & Ethambutol Ocular Toxicity
Modern tuberculosis (TB) treatment relies on multi-drug regimens,
usually over a 6-month period, using first-line anti-TB drugs:
DrugAbbreviationFunction
Isoniazid | H | Bactericidal |
Rifampin | R | Bactericidal |
Ethambutol | E | Resistance prevention |
Pyrazinamide | Z | Rapid kill effect |
✅ Standard protocol: 2 HREZ / 4 HR
- First 2 months: H, R, E, Z
- Next 4 months: H, R
💊 Fixed-Dose Combinations (FDC)
To improve adherence, FDCs combine 2–4 drugs into single tablets.
Effectiveness is comparable to separate dosing.
NameIncluded drugsDuration
TUBIS | H+R+E+Z | 2 months |
TUBIS-TWO | H+R | 4 months |
⚠ Ethambutol-Induced Optic Neuropathy (EON)
- Occurs in 1–5% of patients
- Up to 50% risk of irreversible vision loss, even after stopping medication
❓ Why does it occur?
- 📉 Overdose? → Most regimens stay under 20 mg/kg
- 📆 Duration? → Typically used only for 2 months
➡️ Toxicity occurs even within standard guidelines, suggesting individual susceptibility plays a major role
✅ Summary
- Ethambutol is effective but carries a known risk of optic nerve damage
- Visual monitoring is essential during treatment
- Prompt eye evaluation is crucial if any visual symptoms arise
- Physicians should be aware of EON risk, even in standard dosing
Comments